GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Celgene Corporation (CELG) [hlAlert]

Rating:
Buy CELG
up 51.10 %

Celgene Corporation (CELG) rated Buy with price target $233 by Brean Capital

Posted on: Tuesday,  Jan 14, 2014  10:25 AM ET by Brean Capital

Brean Capital rated Buy Celgene Corporation (NASDAQ: CELG) on 01/14/2014, when the stock price was $81.43. Since
then, Celgene Corporation has gained 51.11% as of 01/14/2016's recent price of $123.04.
If you would have followed this Brean Capital's recommendation on CELG, you would have gained 51.1% of your investment in 730 days.

Celgene Corp. is an independent biopharmaceutical company engaged primarily in the discovery, development and commercialization of orally administered, small molecule drugs for the treatment of cancer and immunological diseases.

Brean Capital
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/14/2014 10:25 AM Buy
None
81.43 116.50
as of 10/17/2014
1 Week down  -3.09 %
1 Month down  -4.48 %
3 Months up  6.00 %
1 YTD up  8.22 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy